UBS strategist Joni Teves is breaking her own rules — so are strategists at Goldman Sachs.
UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €190.00. The ...
Goldman Sachs analyst Andrew Baker maintained a Hold rating on Swiss Re AG (SSREF – Research Report) today and set a price target of CHF139.00.
New banking rules for UBS could face a long delay after Switzerland's finance ministry on Wednesday said it wanted lawmakers ...
Sempra (SRE) rebounds after a steep drop, as Goldman Sachs and UBS downgrade shares citing reduced guidance, uncertainty in growth, and regulatory risks.
UBS strategist Joni Teves is breaking her own rules - so are strategists at Goldman Sachs. "It is always tricky to chase the market higher and uncomfortable when everyone seems to be on the same ...
Goldman Sachs' CEO touched on the growth around the firm's private wealth management platform and how the market is ...
Gold's (GC=F) glittering run in 2025 may have more room to rise higher, Goldman Sachs believes. On Tuesday, the investment ...
Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...
Symbotic (NASDAQ:SYM – Get Free Report) had its price target dropped by analysts at UBS Group from $32.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports.